|
CataraseDrug - Catarase The trade name of the product as shown on the labeling.
Dosage -
FOR SOLUTION; OPHTHALMIC
Active Ingredient(s) -
Chymotrypsin
Strength -
150 UNITS/VIAL
Applicant -
NOVARTIS
New Drug Application (NDA) Number -
018121
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Novartis Pharmaceuticals Corp
Catarase
Catarase 150 Units/vial For Solution; Ophthalmic
Ovidrel Eq 0.25mg /0.5ml Injectable; Subcutaneous Chromic Chloride Eq 0.004mg Chromium/ml Injectable; Injection Chromic Chloride In Plastic Container Eq 0.004mg Chromium/ml Injectable; Injection Phosphocol P32 5mci/ml Injectable; Injection Chymodiactin 10,000 Units/vial **federal Register Determination That Product Was Not Discontinued Or Withdrawn For Safety Or Efficacy Reasons** Injectable; Injection Chymodiactin 4,000 Units/vial Injectable; Injection Discase 12,500 Units/vial Injectable; Injection Alpha Chymar 750 Units/vial For Solution; Ophthalmic Catarase 300 Units/vial For Solution; Ophthalmic NewDrugInformation |